Mr. Eric Resnick has been Chief Technology Officer and Vice President at West Pharmaceutical Services, Inc. since April 1, 2016. Mr. Resnick is responsible for leading West’s Innovation and Technology Team, which has been established to identify and develop the next generation of packaging, containment, and drug delivery products, processes and services. Mr. Resnick previously held a number of leadership roles within West, including Vice President & General Manager, Integrated Packaging & Delivery, as well as Vice President and General Manager of West’s Contract Manufacturing Drug Delivery Device business unit in Tempe, AZ. Prior to joining West, Mr. Resnick held engineering and operating roles with Eastman Kodak and Ortho Clinical Diagnostics. He is a certified Six Sigma Black Belt with a BS in Plastics Engineering from the University of Massachusetts Lowell and an MBA from the University of Phoenix.
Mr. Samson, founder and CEO of Samson Medical Technologies and Chairman of the Board of Trustees of the University of the Sciences, was formerly a Group Vice President – Worldwide Injectables of Teva, previously having served as CEO and a member of the Board of Directors of Sicor (acquired in 2004 by Teva for $3.4 billion). He was also the CEO of Qualitest Pharmaceuticals. He is an expert in injectable manufacturing and delivery systems and was a founder and CEO of Elkins-Sinn (today, West-Ward Pharmaceuticals, one of the largest generic injectables companies in the U.S.) and Marsam Pharmaceuticals.
Dr. Ron is a physician and attorney. She has extensive medical, legal and management experience in insurance companies, law firms, medical and educational institutions. Her legal and management expertise includes venture capital consulting, medical malpractice, general and medical insurance and legal practice. Hadar holds an MD from the Sackler School of Medicine, Tel Aviv University, and an LL.B. in Law from Tel Aviv University.
CEO of Elcam Medical ACS Ltd., a leading worldwide OEM supplier, servicing the medical industry in the area of Fluid Management, Vital Signs Monitoring and Drug Delivery, and the chairman of Elcam Medical US. Igal was Elcam Medical C.F.O since 1998 and holding Israeli CPA.
Eylon Penchas acts as Managing General Partner of Viola Partners (part of the Viola Group) from 2000. Eylon serves as a board member in several of the Viola Partners portfolio companies. He is also the Active Chairman of the Natie Kirsh Seed Fund – a philanthropic fund helping entrepreneurs start their new businesses with free interest loans. Prior to joining Viola Eylon acted as an investment banker at DS from 1997. Prior to joining DS Eylon served as Director of Business Development at Bezeq Telecommunications and as a Research Analyst at the Central Bank of Israel. Eylon holds a B.A. in Economics and an MBA in Finance from the Hebrew University in Jerusalem.
Dr. Yeshurun brings two decades of MEMS and advanced materials R&D expertise to NanoPass. His work integrates both commercial and academic experience. Dr. Yeshurun has an established history in bringing multi-million dollar technology-intensive projects from a concept to the market. Dr. Yeshurun earned his B.Sc. in Mechanical engineering at the Beer Sheva University, and his M.Sc. and PhD in Advanced Materials at the Technion Institute of Technology. A prolific scholar, Dr. Yeshurun has authored over 40 professional publications and 50 classified reports. He is a lecturer at the Technion Institute. A Senior Scientist at NATIONAL LAB, Dr. Yeshurun was a group leader in charge of developing piezoelectric materials for MEMS applications. Dr. Yeshurun holds over a dozen patents and was awarded the American Ceramic Society “Rose” Award for his work. He serves as member of the Board of Directors.